A study on the pharmacokinetics and pharmacodynamics of remimazolam during total intravenous anesthesia with remifentanil
Not Applicable
- Conditions
- Not Applicable
- Registration Number
- KCT0007066
- Lead Sponsor
- Inje University Busan Paik Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
the patients who undergoing general anesthesia during regular surgery at Busan Paik Hospital, aged 18 to 85 and rated 1 to 3 class by the American Society of Anesthesia classification
Exclusion Criteria
Patients with difficulty in communication, hypersensitivity to benzodiazepine or flumagenyl, neurological disorders (such as cognitive impairment, dementia etc.) that may affect cognitive function, past history within three months or current use of drugs that affect the central nervous system (such as antipsychotics, antidepressants, anti-anxiety drugs, anticonvulsants, etc.), alcohol addiction within two years, a history of alcohol dependence
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method blood concentration of remimazolam
- Secondary Outcome Measures
Name Time Method